SecBot SecBot
PTAB-TRIAL ·Filed Nov 10, 2026

META

Meta Platforms, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed6d 8h ago PTABPTAB Decision · ptacts.uspto.gov
PTAB institution decision (instituted)
Actionable Insight • Neutral

The institution grant opens a trial phase expected to conclude with a final written decision within about 12 months. Monitor for the final decision and any related district-court or ITC litigation that the decision may reference in subsequent papers.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$641.39
T+0 close · Nov 10, 2026 · via day close
Latest settled
−1.97%
T+1 · $628.77
Vs SPY
−3.29%
α at T+1
Next horizon
T+5
in 9h
  1. T+0 · Nov 10 $641.39entry
  2. T+1 · 6d ago −1.97%α −3.29% · $628.77
  3. T+4 · todayOpen
  4. T+5 · in 9h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

Executive Summary

The PTAB instituted inter partes review (IPR2026-00376) of Solos Technology Limited's patent covering eyewear systems, apparatus, and methods for providing assistance to a user. Meta Platforms, Inc., as a co-petitioner, cleared the threshold for trial on the challenged claims; no claims have been cancelled yet.

PTAB Trial Details

Proceeding
IPR2026-00376
Proceeding Type
IPR (inter partes review)
Decision
Trial instituted
Company Role
Petitioner
Outcome for Patent Owner
Pending (trial to come)
Patent
U.S. 12,216,339
Patent Covers
eyewear systems, apparatus, and methods for providing assistance to a user
Challenged Claims
not stated in the provided excerpt
Next Step
Trial instituted; a final written decision is due within approximately 12 months

Key Facts

  • PTAB instituted IPR2026-00376 on November 10, 2026
  • Patent: U.S. 12216339, 'EYEWEAR SYSTEMS, APPARATUS, AND METHODS FOR PROVIDING ASSISTANCE TO A USER'
  • Patent owner: Solos Technology Limited
  • Petitioners: Luxottica of America Inc.; Meta Platforms, Inc.
  • Institution granted means the Board found a reasonable likelihood Meta would prevail on at least one challenged claim
  • This is an interlocutory decision; no claims have been cancelled

Financial Impact

No financial figures stated in the decision; the patent covers eyewear systems, which may relate to Meta's smart glasses products, but no revenue or damages are quantified

Risk Factors

  • Interlocutory ruling only, no claims have been invalidated; the patent remains in force
  • If the final written decision cancels claims covering Meta's smart glasses products, it could reduce infringement risk; if claims survive, Meta may face continued exposure
  • No related litigation or product-specific revenue exposure is stated in the decision

Market Snapshot

Price
$639.61
Change
-0.3%
Volume
40
Exchange
Nasdaq
Sector
Services-Computer Programming, Data Processing, Etc.
Analyst Consensus
88% bullish (69 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 PTAB decision.

DocumentAccession Number
PTAB-TRIAL Data (Synthetic)ptab-IPR2026-00376-ins-META

Track record

175 reports on META

Performance horizon

19 of 35 bullish or bearish reports moved the stock their way by T+1. Best: +31.62% at T+20 after the Aug 26, 2026 report. 25 of 35 went positive at some point.

Filters
  1. Nov 13, 20264d ago Court Ruling Bullish 5/10 No price data
  2. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $641.69 to $626.41 Now $626.41 −2.38% ▼ −2.38% −0.47% vs SPY
  3. Nov 12, 20264d ago 8-K Neutral 3/10 Entry $641.69 to $626.41 Now $626.41 −2.38% ▼ −2.38% −0.47% vs SPY
  4. Nov 12, 20265d ago Court Ruling Neutral 2/10 Entry $641.69 to $626.41 Now $626.41 −2.38% ▼ −2.38% −0.47% vs SPY
  5. Nov 10, 20267d ago PTAB Trial Neutral 3/10 Viewing Entry $641.39 to $628.77 Now $626.41 −2.34% ▼ −1.97% −3.29% vs SPY
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $641.39 to $628.77 Now $626.41 −2.34% ▼ −1.97% −3.29% vs SPY
  7. Nov 6, 202610d ago 424B5 Neutral 3/10 Entry $610.15 to $641.37 Now $626.41 +2.66% ▲ +5.12% +2.75% vs SPY
  8. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $610.15 to $641.37 Now $626.41 +2.66% ▲ +5.12% +2.75% vs SPY
  9. Nov 4, 202612d ago 424B5 Neutral 3/10 Entry $605.08 to $610.15 Now $626.41 +3.53% ▲ +0.84% +0.53% vs SPY
  10. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $605.08 to $610.15 Now $626.41 +3.53% ▲ +0.84% +0.53% vs SPY
Showing 10 of 175

US Market Status

Market Closed · Opens Wed (11h 2m)

Subscribe to SecBot

Get Real-Time PTAB Decision Intelligence

Market-moving PTAB patent decisions analyzed within minutes. Trial institutions, denials, final written decisions, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ PTAB Decision · ptacts.uspto.gov Report published Nov 10, 2026